326 related articles for article (PubMed ID: 3257544)
1. A soluble form of CD4 (T4) protein inhibits AIDS virus infection.
Deen KC; McDougal JS; Inacker R; Folena-Wasserman G; Arthos J; Rosenberg J; Maddon PJ; Axel R; Sweet RW
Nature; 1988 Jan; 331(6151):82-4. PubMed ID: 3257544
[TBL] [Abstract][Full Text] [Related]
2. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
Hussey RE; Richardson NE; Kowalski M; Brown NR; Chang HC; Siliciano RF; Dorfman T; Walker B; Sodroski J; Reinherz EL
Nature; 1988 Jan; 331(6151):78-81. PubMed ID: 2829023
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
Traunecker A; Lüke W; Karjalainen K
Nature; 1988 Jan; 331(6151):84-6. PubMed ID: 2829024
[TBL] [Abstract][Full Text] [Related]
4. HIV infection is blocked in vitro by recombinant soluble CD4.
Fisher RA; Bertonis JM; Meier W; Johnson VA; Costopoulos DS; Liu T; Tizard R; Walker BD; Hirsch MS; Schooley RT
Nature; 1988 Jan; 331(6151):76-8. PubMed ID: 2829022
[TBL] [Abstract][Full Text] [Related]
5. Receptor molecule blocks HIV.
Weiss RA
Nature; 1988 Jan; 331(6151):15. PubMed ID: 2829021
[No Abstract] [Full Text] [Related]
6. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
Clayton LK; Sieh M; Pious DA; Reinherz EL
Nature; 1989 Jun; 339(6225):548-51. PubMed ID: 2543930
[TBL] [Abstract][Full Text] [Related]
7. Structural features of CD4 required for binding to HIV.
Ibegbu CC; Kennedy MS; Maddon PJ; Deen KC; Hicks D; Sweet RW; McDougal JS
J Immunol; 1989 Apr; 142(7):2250-6. PubMed ID: 2538505
[TBL] [Abstract][Full Text] [Related]
8. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
McDougal JS; Nicholson JK; Cross GD; Cort SP; Kennedy MS; Mawle AC
J Immunol; 1986 Nov; 137(9):2937-44. PubMed ID: 2428879
[TBL] [Abstract][Full Text] [Related]
9. Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules.
Traunecker A; Schneider J; Kiefer H; Karjalainen K
Nature; 1989 May; 339(6219):68-70. PubMed ID: 2541344
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.
Weinhold KJ; Lyerly HK; Stanley SD; Austin AA; Matthews TJ; Bolognesi DP
J Immunol; 1989 May; 142(9):3091-7. PubMed ID: 2468713
[TBL] [Abstract][Full Text] [Related]
11. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4.
Landau NR; Warton M; Littman DR
Nature; 1988 Jul; 334(6178):159-62. PubMed ID: 3260352
[TBL] [Abstract][Full Text] [Related]
12. [HIV envelope proteins are bound by human epidermal Langerhans cells by a binding site which differs from the site on the CD4 molecule, and are internalized by receptor endocytosis].
Schmitt D; Dezutter-Dambuyant C; Hanau D; Schmitt DA; Kolbe HV; Kieny MP; Cazenave JP; Thivolet J
C R Acad Sci III; 1989; 308(10):269-75. PubMed ID: 2543485
[TBL] [Abstract][Full Text] [Related]
13. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
[TBL] [Abstract][Full Text] [Related]
14. HIV infection of primate lymphocytes and conservation of the CD4 receptor.
McClure MO; Sattentau QJ; Beverley PC; Hearn JP; Fitzgerald AK; Zuckerman AJ; Weiss RA
Nature; 1987 Dec 3-9; 330(6147):487-9. PubMed ID: 2446142
[TBL] [Abstract][Full Text] [Related]
15. HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis.
Mann DL; Lasane F; Popovic M; Arthur LO; Robey WG; Blattner WA; Newman MJ
J Immunol; 1987 Apr; 138(8):2640-4. PubMed ID: 3031162
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells.
Clapham PR; Weber JN; Whitby D; McIntosh K; Dalgleish AG; Maddon PJ; Deen KC; Sweet RW; Weiss RA
Nature; 1989 Jan; 337(6205):368-70. PubMed ID: 2536142
[TBL] [Abstract][Full Text] [Related]
17. Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein.
Chaudhary VK; Mizukami T; Fuerst TR; FitzGerald DJ; Moss B; Pastan I; Berger EA
Nature; 1988 Sep; 335(6188):369-72. PubMed ID: 2843774
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte activation by HIV-1 envelope glycoprotein.
Kornfeld H; Cruikshank WW; Pyle SW; Berman JS; Center DM
Nature; 1988 Sep; 335(6189):445-8. PubMed ID: 2843775
[TBL] [Abstract][Full Text] [Related]
19. The role of CD4 in HIV binding and entry.
Sattentau QJ; Moore JP
Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):59-66. PubMed ID: 7904348
[TBL] [Abstract][Full Text] [Related]
20. T cells can present antigens such as HIV gp120 targeted to their own surface molecules.
Lanzavecchia A; Roosnek E; Gregory T; Berman P; Abrignani S
Nature; 1988 Aug; 334(6182):530-2. PubMed ID: 2841610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
